pharma · Premature Birth
PAUL HARTMANN S.P.A
Paul Hartmann Pty Ltd
Paul Hartmann Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Premature Birth. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entit
IT HQ
35 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- IT
- Employees
- 35
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Spermine
Phase 1 · mab · Premature Birth
Spermine for Premature Birth is a Phase 1 program (mab) at Paul Hartmann Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code tight junction, spermine
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Paul Hartmann Pty Ltd
- Phase
- Phase 1
- Modality
- mab
- Indication
- Premature Birth
- Status
- completed
- Trials
- 1